Frozen hope: new study offers fertility lifeline for young cancer patients

NCT ID NCT06505057

Recruiting now Disease control Sponsor: Chinese University of Hong Kong Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study offers young female cancer patients the option to freeze a piece of their ovarian tissue before starting cancer treatment, then have it transplanted back later to restore fertility. The goal is to help preserve the chance of having biological children after cancer. Researchers will track surgical safety and pregnancy rates in 100 participants.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Ovarian tissue cryopreservation and auto-transplantation
What this could lead to: If successful, this could help young female cancer patients preserve and later restore their fertility after cancer treatment.
What could go wrong: This is an early-stage service development study with no control group, so results may not apply to all patients. Surgical complications and uncertain pregnancy rates are possible risks.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NEOPLASMS

Contacts and locations

Locations

Hong Kong Children's Hospital
RECRUITING

Hong Kong, Hong Kong

More trials for these conditions

Other studies related to the condition(s) this trial covers.